Profession Notes

Breast Cancer Consensus Conference The National Institutes of Health's Office of Medical Applications of Research (OMAR) will hold a consensus conference Nov. 1-3, 2000, on the NIH campus to discuss adjuvant therapies for breast cancer. The first NIH consensus conference on breast cancer therapy in 10 years, it will address the ins and outs of adjuvant radiation, chemotherapy, and hormonal therapy, as well as promising future directions for related research. As with all consensus conferences, he

Written byEugene Russo
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Breast Cancer Consensus Conference

The National Institutes of Health's Office of Medical Applications of Research (OMAR) will hold a consensus conference Nov. 1-3, 2000, on the NIH campus to discuss adjuvant therapies for breast cancer. The first NIH consensus conference on breast cancer therapy in 10 years, it will address the ins and outs of adjuvant radiation, chemotherapy, and hormonal therapy, as well as promising future directions for related research. As with all consensus conferences, health professionals, researchers, patient advocates, and other members of the public are invited to hear an independent panel of scientists present their findings. Based on the presentations and on public comments, the panel drafts a consensus statement meant to advance the understanding of the issues addressed. To register for the breast cancer conference, send an E-mail to breastcancer@prospectassoc.com or see the NIH Consensus Development Program Web site at odp.od.nih.gov/consensus.

--Eugene Russo

Computational Biology Fellowship

The ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026, Issue 1

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Skip the Wait for Protein Stability Data with Aunty

Skip the Wait for Protein Stability Data with Aunty

Unchained Labs
Graphic of three DNA helices in various colors

An Automated DNA-to-Data Framework for Production-Scale Sequencing

illumina
Exploring Cellular Organization with Spatial Proteomics

Exploring Cellular Organization with Spatial Proteomics

Abstract illustration of spheres with multiple layers, representing endoderm, ectoderm, and mesoderm derived organoids

Organoid Origins and How to Grow Them

Thermo Fisher Logo

Products

Brandtech Logo

BRANDTECH Scientific Introduces the Transferpette® pro Micropipette: A New Twist on Comfort and Control

Biotium Logo

Biotium Launches GlycoLiner™ Cell Surface Glycoprotein Labeling Kits for Rapid and Selective Cell Surface Imaging

Colorful abstract spiral dot pattern on a black background

Thermo Scientific X and S Series General Purpose Centrifuges

Thermo Fisher Logo
Abstract background with red and blue laser lights

VANTAstar Flexible microplate reader with simplified workflows

BMG LABTECH